Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management.
about
Pathophysiology of diabetic retinopathyEvidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy.Alterations in the intraocular cytokine milieu after intravitreal bevacizumab.Involvement of protein kinase CK2 in angiogenesis and retinal neovascularizationAlteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far.Isolation and characterization of vitreous insulin-like growth factor binding proteinsThe pathogenesis of diabetic retinopathy: old concepts and new questions.Nestin positive cells in adult human retina and in epiretinal membranes.Novel Therapies in Development for Diabetic Macular Edema.Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness.TGF-β1 and IGF-I gene variations in type 1 diabetes microangiopathic complicationsDiabetic Retinopathy: Vascular and Inflammatory Disease.Retinal fibrosis in diabetic retinopathyEpo inhibits the fibrosis and migration of Müller glial cells induced by TGF-β and high glucose.Ranibizumab efficiently blocks migration but not proliferation induced by growth factor combinations including VEGF in retinal endothelial cells.Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab.Diabetic retinopathy in acromegalyD-Glucose and insulin stimulate migration and tubular formation of human endothelial cells in vitro.Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cellsVitreous IGFBP-3 effects on Müller cell proliferation and tractional force generation.Lipid factor (bVLF) from bovine vitreous body evokes in EGFR-T17 cells a Ca2+-dependent K+ current associated with inositol 1,4,5-trisphosphate-independent Ca2+ mobilization.Ocular neovascularization: clarifying complex interactions.Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1.Human corneal epithelial basement membrane and integrin alterations in diabetes and diabetic retinopathy.Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes.Bowman Lecture 1998. Diabetic retinopathy: some cellular, molecular and therapeutic considerations.Protective effects of a novel drug RC28-E blocking both VEGF and FGF2 on early diabetic rat retina.
P2860
Q26865897-56D9EC3E-0600-4BA9-9184-B6873FF4EA90Q31918268-3B6D973C-DC03-44A0-8119-57C42670499BQ33845524-AF5D4024-D7BE-481B-A413-F071CFD6AEC0Q34049304-4875E4CC-947C-4CFF-BA03-939C50DD1C19Q34545203-38A2EF87-A087-4C06-A9DB-27268F249D55Q34646657-599FB870-DA9C-42D2-A2DF-69198F85BCA4Q34658478-C1EE61F6-E625-4998-86DD-B46F7E134AA4Q35591359-F937BE0A-9588-4B45-BE88-F6EF102CFF27Q35751912-3266689B-4017-40C3-AB03-0920BF3757AFQ37362491-0B86DCAD-4FAE-499E-AD49-78F24DBF553EQ37714540-11DD41F0-28E0-40BD-9527-0F2250182146Q38542115-42090DDE-1A61-4750-B17C-67AF3FD63347Q38671308-A4AE4B99-18D6-4581-86C2-A4948237A760Q38791580-0174B5A9-84E4-4D24-9C49-6A2D5E0F752CQ39140339-C16D48A3-2204-49DB-A3A6-E03CB8BA831AQ40196662-E12B2481-E0ED-4209-8C69-5AE52B326803Q40658820-8FC75D39-7DD0-48C2-9206-FE49E48C4292Q40929400-C231E259-1DC9-4286-9CB0-CE41EF1D2860Q41947979-E247892A-1622-4473-B996-4B11E4B68712Q41998096-34DA64F1-66AE-4C02-98FC-86AF5EDCA1A2Q42804893-0DB81091-3D4E-4602-AC98-7637382FC5A2Q42850925-A3CD4930-1AE2-4498-A01D-66C2A5CBD855Q44763476-A61F4063-48FC-47CF-BA81-68EA91FFB05EQ46206222-9561A6EE-D6BA-466B-BEC0-F5BA2DD71DE0Q47130506-5A18E0CD-28C5-4CFD-801B-2EFC8D6BBB39Q48580864-025AD459-55D1-4B7F-B217-1CE398FAA802Q55414211-415942DC-E91D-43EC-9117-B5CA6E2AD445
P2860
Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Intravitreal growth factors in ...... vity and glycaemic management.
@ast
Intravitreal growth factors in ...... vity and glycaemic management.
@en
type
label
Intravitreal growth factors in ...... vity and glycaemic management.
@ast
Intravitreal growth factors in ...... vity and glycaemic management.
@en
prefLabel
Intravitreal growth factors in ...... vity and glycaemic management.
@ast
Intravitreal growth factors in ...... vity and glycaemic management.
@en
P2093
P2860
P356
P1476
Intravitreal growth factors in ...... vity and glycaemic management.
@en
P2093
Bardsley B
Charteris D
Jarvis-Evans J
Moriarty P
P2860
P304
P356
10.1136/BJO.81.3.228
P407
P577
1997-03-01T00:00:00Z